Prediction: New Reason Lilly Stock Could Still Rise
Eli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
Compare brokers on costs, ease of use, and research tools to find the best fit for your index fund investing journey.
22,899 articlesEli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
Ericsson's 2026 earnings trajectory hinges on 5G expansion, services, and software. This guide breaks down what to wa...
Wildfire smoke blankets major U.S. cities, pushing air quality warnings higher and nudging investment flows toward cl...
In the first half of 2026, american superconductor corporation rallied as grid modernization and superconducting tech...
Oracle's shares have fallen steeply as AI hype cooled. This article breaks down whether the stock is a value opportun...
In a market chasing AI hype, two heavyweight tech names stand out as compelling bargains. This article explains why N...
Palo Alto Networks’ stock fell after the latest earnings, as traders weighed a murky near-term outlook against the co...
A single housing metric has crossed a major milestone, signaling potential changes in loan access and affordability. ...
When a legendary investor shifts big positions, traders sit up. This piece breaks down what it could mean that billio...
Amazon stock has cooled after a strong run, but bulls argue AI investments, AWS momentum, and ad growth could fuel a ...
Bitcoin’s rising hodl cohorts underscore a defensive market, with on-chain metrics showing persistent outflows, minim...
Steve Madden Ltd. will not provide earnings guidance for the upcoming quarter after a Supreme Court tariff ruling inj...